Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
3.300
-0.020 (-0.60%)
At close: Apr 28, 2026, 4:00 PM EDT
3.260
-0.040 (-1.21%)
After-hours: Apr 28, 2026, 5:59 PM EDT
Biodexa Pharmaceuticals Market Cap
Biodexa Pharmaceuticals has a market cap or net worth of $2.14 million as of April 28, 2026. Its market cap has decreased by -52.82% in one year.
Market Cap
2.14M
Enterprise Value
-9.23M
1-Year Change
-52.82%
Ranking
Category
Stock Price
$3.30
Market Cap Chart
Since February 26, 2019, Biodexa Pharmaceuticals's market cap has decreased from $102.08M to $2.14M, a decrease of -97.90%. That is a compound annual growth rate of -41.66%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oragenics | 2.78M |
| Silexion Therapeutics | 2.61M |
| Scinai Immunotherapeutics | 2.56M |
| HCW Biologics | 2.53M |
| Calidi Biotherapeutics | 2.50M |
| Bone Biologics | 2.44M |
| Propanc Biopharma | 2.30M |
| Adial Pharmaceuticals | 2.26M |